Guillaume Dachy

11PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Bioprocessing, bioproduction and bioproductsProcess control and simulationHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 06, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

|Dec 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link.

Ugo Chartral, Jeanne Galaine, Camille Giverne

|Jun 30, 2025
Correction: Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium.

Chrystel Marton, Béatrice Clémenceau, Guillaume Dachy

|Jun 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.

Guillaume Dachy, Myriam Labopin, Gérard Socié

|May 29, 2025
Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium.

Chrystel Marton, Béatrice Clémenceau, Guillaume Dachy

|Apr 09, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Guillermo Ortí, Guillaume Dachy, Charlotte E Graham

Pageof 2

Frequent Collaborators

5 joint publications

Edouard Forcade

4 joint publications

Sébastien Viel

4 joint publications

Christophe Ferrand

4 joint publications

Marina Deschamps